JP2002507215A - ５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジン マレイン酸塩 - Google Patents

５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジン マレイン酸塩

Info

Publication number
JP2002507215A
JP2002507215A JP50616699A JP50616699A JP2002507215A JP 2002507215 A JP2002507215 A JP 2002507215A JP 50616699 A JP50616699 A JP 50616699A JP 50616699 A JP50616699 A JP 50616699A JP 2002507215 A JP2002507215 A JP 2002507215A
Authority
JP
Japan
Prior art keywords
acid addition
maleic acid
addition salt
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50616699A
Other languages
English (en)
Japanese (ja)
Inventor
ゾンマー・ミヒャエル ベッヘ
ニールセン・オレ
Original Assignee
ハー・ルンドベック・アクティーゼルスカブ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハー・ルンドベック・アクティーゼルスカブ filed Critical ハー・ルンドベック・アクティーゼルスカブ
Publication of JP2002507215A publication Critical patent/JP2002507215A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP50616699A 1997-07-01 1998-07-01 ５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジン マレイン酸塩 Pending JP2002507215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK0781/97 1997-07-01
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (1)

Publication Number Publication Date
JP2002507215A true JP2002507215A (ja) 2002-03-05

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50616699A Pending JP2002507215A (ja) 1997-07-01 1998-07-01 ５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジン マレイン酸塩

Country Status (25)

Country Link
EP (1) EP0994869A1 (tr)
JP (1) JP2002507215A (tr)
KR (1) KR20010014297A (tr)
CN (1) CN1261361A (tr)
AR (1) AR013096A1 (tr)
AU (1) AU735751B2 (tr)
BG (1) BG103933A (tr)
BR (1) BR9810331A (tr)
CA (1) CA2293324A1 (tr)
CO (1) CO4940483A1 (tr)
EA (1) EA200000081A1 (tr)
HU (1) HUP0002876A2 (tr)
IL (1) IL133093A0 (tr)
IS (1) IS5278A (tr)
JO (1) JO2031B1 (tr)
MA (1) MA25138A1 (tr)
NO (1) NO996580D0 (tr)
PE (1) PE116099A1 (tr)
PL (1) PL337184A1 (tr)
SK (1) SK187399A3 (tr)
TN (1) TNSN98120A1 (tr)
TR (1) TR199903283T2 (tr)
UY (2) UY25069A1 (tr)
WO (1) WO1999001448A1 (tr)
ZA (1) ZA985498B (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
WO1997017074A1 (en) * 1995-11-06 1997-05-15 H. Lundbeck A/S Treatment of traumatic brain injury

Also Published As

Publication number Publication date
BR9810331A (pt) 2000-09-05
EP0994869A1 (en) 2000-04-26
CN1261361A (zh) 2000-07-26
UY25177A1 (es) 2000-12-29
MA25138A1 (fr) 2001-04-02
HUP0002876A2 (hu) 2001-06-28
IS5278A (is) 1999-11-30
AU735751B2 (en) 2001-07-12
EA200000081A1 (ru) 2000-08-28
PL337184A1 (en) 2000-08-14
KR20010014297A (ko) 2001-02-26
AU8102098A (en) 1999-01-25
SK187399A3 (en) 2000-06-12
PE116099A1 (es) 1999-11-23
IL133093A0 (en) 2001-03-19
NO996580L (no) 1999-12-30
TNSN98120A1 (fr) 2005-03-15
CA2293324A1 (en) 1999-01-14
ZA985498B (en) 1999-01-20
CO4940483A1 (es) 2000-07-24
AR013096A1 (es) 2000-12-13
WO1999001448A1 (en) 1999-01-14
UY25069A1 (es) 1998-12-21
JO2031B1 (en) 1999-05-15
NO996580D0 (no) 1999-12-30
TR199903283T2 (tr) 2000-06-21
BG103933A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
AU2005209473B2 (en) Polymorphic forms of a GABAA agonist
EP2603509B1 (en) Crystalline form of pyrimido[6,1-a] isoquinolin-4-one compound
JP2001512109A (ja) 結晶性ジベンゾチアゼピン誘導体およびその抗精神病薬としての使用
RU2613555C2 (ru) Моногидратный кристалл калиевой соли фимасартана, способ его получения и содержащая его фармакологическая композиция
BG64746B1 (bg) Състав за орално приложение, съдържащ левосимендан
WO2002064557A2 (en) New crystal forms of oxcarbazepine and processes for their preparation
JPH09510222A (ja) ２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピン化合物の酸付加塩
EP2292222A1 (en) Polymorphic Forms of a GABAA Agonist
CN114773336B (zh) 一种游离态plx5622晶型及其制备方法
JP2002532494A (ja) パロキセチンの誘導体
JP2002535406A (ja) ４−オキソ−３，５−ジヒドロ−４Ｈ−ピリダジノ［４，５−ｂ］インドール−１−カルボキサミド誘導体、それらの製造、および治療におけるそれらの適用
JP2002507215A (ja) ５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジン マレイン酸塩
JP2002511466A (ja) マレイン酸パロキセチン
JPH08511008A (ja) 複素環式化学
CZ477899A3 (cs) 5-(2-ethyI-2H-tetrazol-5-yl)-l-methyl-l,2,3,6- tetrahydropyridinmaleátová adiční sůl
MXPA99011450A (en) 5-(2-ethyl-2h
JPH07509472A (ja) ラクタム誘導体
JP2002531453A (ja) パロキセチン塩酸塩アセトン溶媒和物の製法
JPH10503532A (ja) レソピトロン二塩酸塩の新規多形およびその水和形その製造方法およびそれを含有する組成物
JP2002531450A (ja) パロキセチン・塩酸塩の製造方法